Gastroenterology Practice Questions

Q: The diagnosis of neuroendocrine tumor (NET) of the small bowel is made by which investigation?

24-hour urinary 5-HIAA (5-hydroxyindoleacetic acid). **Explanation:** The correct answer is **C. 24-hour urinary 5-HIAA**. **1. Why 5-HIAA is the correct answer:** Small bowel neuroendocrine tumors (NETs), historically called carcinoid tumors, are derived from enterochromaffin cells. These cells frequently produce **serotonin** (5-hydroxytryptamine). Serotonin is metabolized by the liver and lungs into **5-hydroxyindoleacetic acid (5-HIAA)**, which is then excreted in the urine. A 24-hour urinary 5-HIAA test has high specificity (approx. 90%) for diagnosing carcinoid syndrome, which typically occurs when a small bowel NET has metastasized to the liver, allowing serotonin to bypass hepatic metabolism and enter the systemic circulation. **2. Why the other options are incorrect:** * **Options A & B (Metanephrines and VMA):** These are metabolites of catecholamines (epinephrine and norepinephrine). They are the gold-standard biochemical markers for diagnosing **Pheochromocytoma** and **Paraganglioma**, not NETs of the bowel. * **Option D (Urinary Cortisol):** 24-hour urinary free cortisol is used as a screening test for **Cushing’s Syndrome** to evaluate hypercortisolism. **Clinical Pearls for NEET-PG:** * **Most common site of NET:** The **Appendix** is the most common site overall (often an incidental finding), but the **Ileum** is the most common site for symptomatic/metastatic NETs. * **Carcinoid Syndrome Triad:** Flushing (most common), Diarrhea, and Right-sided heart failure (Tricuspid regurgitation/Pulmonary stenosis). * **Diagnostic Imaging:** **Ga-68 DOTATATE PET/CT** is currently the most sensitive imaging modality for localizing NETs (superior to the older Octreoscan). * **Dietary Note:** Patients must avoid serotonin-rich foods (bananas, walnuts, avocados) for 48 hours before the 5-HIAA test to prevent false positives.

Q: Which part of the esophagus is mainly affected in scleroderma?

Lower third. **Explanation:** The correct answer is **C. Lower third.** **1. Why the Lower Third is affected:** Systemic Sclerosis (Scleroderma) primarily affects **smooth muscle**. The esophagus is anatomically divided by its muscle composition: the upper third consists of skeletal muscle, the middle third is a transition zone, and the **lower two-thirds** consist entirely of smooth muscle. In Scleroderma, vascular damage and fibrosis lead to atrophy of the smooth muscle and dysfunction of the myenteric plexus [1]. This results in: * **Aperistalsis** of the distal (lower) esophagus [1]. * **Incompetence of the Lower Esophageal Sphincter (LES)**, leading to severe Gastroesophageal Reflux Disease (GERD) and potential strictures [1]. **2. Why other options are incorrect:** * **Option A (Upper third):** This segment is composed of **striated (skeletal) muscle**. Diseases affecting this area include Dermatomyositis, Myasthenia Gravis, or Myotonic Dystrophy, rather than Scleroderma [1]. * **Option B (Middle third):** While the middle third contains some smooth muscle and can be partially involved, the pathological hallmark of Scleroderma is most profound in the distal smooth muscle segment and the LES. * **Option D (All the above):** Scleroderma characteristically spares the skeletal muscle of the proximal esophagus. **Clinical Pearls for NEET-PG:** * **CREST Syndrome:** Esophageal dysmotility is the 'E' in CREST [1]. * **Manometry Findings:** Characterized by "Low-amplitude" or absent contractions in the distal esophagus and a "Hypotensive" (low pressure) LES. * **Barrett’s Esophagus:** Due to chronic, severe reflux from a patulous LES, Scleroderma patients are at high risk for Barrett’s and esophageal adenocarcinoma. * **"Glass Pipe" Esophagus:** A radiological description sometimes used for the dilated, aperistaltic esophagus seen on barium swallow.

Q: Which is a feature of osmotic diarrhea?

Decreases/stops with fasting. **Explanation:** The core pathophysiology of **osmotic diarrhea** is the presence of non-absorbable, osmotically active solutes in the intestinal lumen. These solutes draw water into the gut to maintain isotonicity, leading to increased stool water [1]. **1. Why Option B is Correct:** Osmotic diarrhea is driven by the ingestion of specific substances (e.g., lactose in lactase deficiency, magnesium salts, or sorbitol) [1]. When a patient is **fasting**, the offending solute is no longer being ingested. Consequently, the osmotic gradient disappears, and the diarrhea **decreases or stops**. This is the classic clinical hallmark that differentiates it from secretory diarrhea [2]. **2. Why the other options are incorrect:** * **Option A (Volume >1 litre):** Large volume stools (>1 L/day) are characteristic of **secretory diarrhea** (e.g., Cholera, VIPoma). Osmotic diarrhea typically results in smaller volumes, usually 125 mOsm/kg)** because the measured electrolytes (Na+ and K+) do not account for the total osmolality; the "gap" is filled by the unmeasured non-absorbable solute. A gap 125); Stool pH is often acidic (due to bacterial fermentation of carbohydrates) [2].

Q: A 43-year-old woman has a 10-year history of severe and recurrent peptic ulcer disease (PUD) that is refractory to medical therapy. She has ulcers at multiple sites of the small bowel including the distal duodenum and jejunum. She also has chronic diarrhea, but not enough fat to make the diagnosis of steatorrhea. Evaluation for Helicobacter pylori infection is negative. What is the most likely diagnosis for this patient with these gastrointestinal symptoms?

Gastrinoma. The clinical presentation of recurrent, refractory peptic ulcers located in atypical sites (distal duodenum and jejunum) combined with chronic diarrhea is classic for **Zollinger-Ellison Syndrome (ZES)**, caused by a **Gastrinoma**. **1. Why Gastrinoma is correct:** Gastrinomas are neuroendocrine tumors (usually in the pancreas or duodenum) that secrete excessive gastrin. This leads to massive gastric acid hypersecretion. * **Ulcers:** High acid levels cause multiple ulcers, often in the post-bulbar duodenum and jejunum (atypical locations). * **Diarrhea:** The high volume of acid enters the small intestine, overwhelming the neutralizing capacity of pancreatic bicarbonate. This leads to mucosal damage and inactivation of pancreatic lipase, causing malabsorption and diarrhea. **2. Why other options are incorrect:** * **Celiac Sprue:** While it causes diarrhea and malabsorption, it does not cause severe peptic ulceration or gastric acid hypersecretion. * **Associated decrease in pancreatic enzymes:** While pancreatic enzymes (like lipase) are indeed **inactivated** by the low pH in ZES, the primary diagnosis is the tumor itself (Gastrinoma). A "decrease" in production is not the underlying pathology. * **Hypersensitivity reaction:** This typically presents with urticaria, angioedema, or anaphylaxis, not chronic refractory peptic ulcers. **Clinical Pearls for NEET-PG:** * **Diagnosis:** Best initial test is **Fasting Serum Gastrin** (>1000 pg/mL is diagnostic). [1] The most specific provocative test is the **Secretin Stimulation Test** (Gastrin rises >200 pg/mL). * **Localization:** Most gastrinomas are found within the **"Gastrinoma Triangle"** (confluence of cystic/common bile duct, junction of 2nd/3rd parts of duodenum, and neck/body of pancreas). * **Association:** 25% of cases are associated with **MEN-1 syndrome** (3 Ps: Parathyroid, Pancreas, Pituitary).

Q: In a patient with anemia, a low MCV, and a negative fecal occult blood, what is the most likely underlying gastrointestinal disease?

Celiac disease. The patient presents with **microcytic anemia** (low MCV), suggesting iron deficiency, but has a **negative fecal occult blood test (FOBT)**. This indicates that the iron deficiency is likely due to **malabsorption** rather than chronic occult blood loss [4]. **1. Why Celiac Disease is Correct:** Celiac disease is an immune-mediated enteropathy that primarily affects the **duodenum and proximal jejunum**—the primary sites for iron absorption [1]. Villous atrophy leads to impaired iron uptake [3]. Because the pathology is malabsorptive and not typically erosive, these patients often present with refractory iron deficiency anemia and a **negative FOBT**, making it a classic "hidden" cause of anemia in clinical exams [1]. **2. Why the Other Options are Incorrect:** * **Peptic Ulcer Disease (A):** This causes anemia through chronic, slow bleeding. Therefore, the FOBT would typically be **positive** [2]. * **Alcoholic Liver Disease (B):** Anemia in liver disease is usually **macrocytic** (due to direct toxicity, folate deficiency, or spur cell anemia) or normocytic. If microcytic anemia occurs due to variceal bleeding, the FOBT or overt melena would be present. * **Hookworm Infestation (C):** *Ancylostoma duodenale* and *Necator americanus* cause iron deficiency by sucking blood from the intestinal mucosa [2]. This blood loss results in a **positive FOBT**. **3. NEET-PG High-Yield Pearls:** * **Gold Standard Diagnosis:** Intestinal biopsy showing villous atrophy, crypt hyperplasia, and increased intraepithelial lymphocytes [3]. * **Serology:** Anti-tissue transglutaminase (anti-tTG) IgA is the screening test of choice [3]. * **Associated HLA:** HLA-DQ2 and HLA-DQ8 [3]. * **Dermatological Association:** Dermatitis herpetiformis (intensely pruritic vesicles on elbows/knees). * **Clinical Hint:** Always suspect Celiac disease in a patient with iron deficiency anemia that does not respond to oral iron therapy [1].

Q: What is the drug of choice for an acute exacerbation of ulcerative colitis?

Corticosteroids. **Explanation:** **Correct Answer: D. Corticosteroids** The primary goal in an **acute exacerbation** of Ulcerative Colitis (UC) is to induce rapid remission by suppressing intense systemic and local inflammation. **Corticosteroids** (e.g., oral Prednisolone or IV Hydrocortisone/Methylprednisolone) are the **drugs of choice for inducing remission** in moderate-to-severe acute flares due to their potent anti-inflammatory effects and rapid onset of action. However, they are never used for maintenance therapy due to significant long-term side effects. **Why other options are incorrect:** * **A. Sulfasalazine:** This is a 5-ASA (Aminosalicylate) derivative. While it is the drug of choice for **maintaining remission** and treating mild-to-moderate UC, it is not potent enough to manage an acute, severe exacerbation. * **B. Methotrexate:** This is an immunomodulator used primarily in Crohn’s disease. It has a slow onset of action (weeks to months) and is ineffective for the rapid control required during an acute flare. * **C. Infliximab:** This TNF-α inhibitor is used as "rescue therapy" in patients who are **refractory to corticosteroids**. While highly effective, it is generally considered a second-line option for acute flares after steroids have failed. **High-Yield Clinical Pearls for NEET-PG:** * **Induction of Remission:** Corticosteroids (Topical for proctitis, Oral/IV for systemic disease). * **Maintenance of Remission:** 5-ASA (Sulfasalazine/Mesalamine). * **Site of Action:** Sulfasalazine is cleaved by colonic bacteria into **Sulfapyridine** (causes side effects) and **5-ASA** (the active therapeutic moiety). * **Toxic Megacolon:** A dreaded complication of acute UC; managed with IV fluids, IV steroids, and bowel rest.

Q: The modified Mayo score is used in clinical trials to assess the severity of which condition?

Ulcerative colitis. The **Mayo Score** is the gold standard clinical scoring system used to evaluate the disease activity and severity of **Ulcerative Colitis (UC)** [1]. It is extensively used in clinical trials to assess treatment response and mucosal healing. **1. Why Ulcerative Colitis is correct:** The original Mayo score consists of four components: * **Stool frequency** (compared to normal) * **Rectal bleeding** * **Physician’s global assessment (PGA)** * **Endoscopic findings** (Sigmoidoscopy/Colonoscopy) [2] The **Modified Mayo Score** (often used in modern trials) excludes the "Physician’s Global Assessment" to make the score more objective, focusing primarily on patient-reported outcomes and endoscopic appearance. **2. Why other options are incorrect:** * **Crohn’s Disease:** The primary scoring system used is the **CDAI (Crohn’s Disease Activity Index)** or the **Harvey-Bradshaw Index (HBI)**. * **Diverticulosis:** Severity is typically graded using the **Hinchey Classification** (specifically for diverticulitis complications). * **Pancreatitis:** Severity is assessed using the **Ranson Criteria**, **APACHE II score**, or the **Modified Glasgow Score**. **High-Yield Clinical Pearls for NEET-PG:** * **Mucosal Healing:** In the Mayo score, an endoscopic sub-score of **0 or 1** is the definition of mucosal healing. * **Truelove and Witts Criteria:** Another high-yield classification for UC, used primarily to categorize "Acute Severe Colitis." * **Montreal Classification:** Used to define the anatomical extent of UC (E1: Proctitis, E2: Left-sided, E3: Extensive/Pancolitis).

Question 1

A 55-year-old male patient was diagnosed with chronic hepatitis C and responded to interferon treatment. After one year of follow-up, he experienced a relapse of the disease. Which of the following would be the next most appropriate choice?

Accepted Answer

Ribavirin and interferon

Answer

Lamivudine and interferon

Answer

Nevirapine and lamivudine

Answer

Indinavir and ribavirin

Question 2

The diagnosis of neuroendocrine tumor (NET) of the small bowel is made by which investigation?

Accepted Answer

24-hour urinary 5-HIAA (5-hydroxyindoleacetic acid)

Answer

24-hour urinary metanephrines

Answer

24-hour urinary VMA (vanillylmandelic acid)

Answer

24-hour urinary cortisol

Question 3

Which part of the esophagus is mainly affected in scleroderma?

Accepted Answer

Lower third

Answer

Upper third

Answer

Middle third

Answer

All the above

Question 4

Which is a feature of osmotic diarrhea?

Accepted Answer

Decreases/stops with fasting

Answer

Volume >1 litre

Answer

Mostly infectious etiology

Answer

Osmotic gap <50 mmol

Question 5

A 43-year-old woman has a 10-year history of severe and recurrent peptic ulcer disease (PUD) that is refractory to medical therapy. She has ulcers at multiple sites of the small bowel including the distal duodenum and jejunum. She also has chronic diarrhea, but not enough fat to make the diagnosis of steatorrhea. Evaluation for Helicobacter pylori infection is negative. What is the most likely diagnosis for this patient with these gastrointestinal symptoms?

Accepted Answer

Gastrinoma

Answer

Celiac sprue

Answer

Associated decrease in pancreatic enzymes

Answer

Hypersensitivity reaction

Question 6

In a patient with anemia, a low MCV, and a negative fecal occult blood, what is the most likely underlying gastrointestinal disease?

Accepted Answer

Celiac disease

Answer

Peptic ulcer disease

Answer

Alcoholic liver disease

Answer

Hookworm infestation

Question 7

A 30-year-old patient has a history of antibodies to HCV for 6 months with normal AST/ALT and no symptoms or stigmata of liver disease. What is the most appropriate approach?

Accepted Answer

Perform liver biopsy and start antiviral drugs accordingly

Answer

Re-assure the patient

Answer

Repeat HCV antibody titer every 3 years

Answer

Repeat liver enzymes yearly

Question 8

What is the drug of choice for an acute exacerbation of ulcerative colitis?

Accepted Answer

Corticosteroids

Answer

Sulfasalazine

Answer

Methotrexate

Answer

Infliximab

Question 9

The modified Mayo score is used in clinical trials to assess the severity of which condition?

Accepted Answer

Ulcerative colitis

Answer

Crohn's disease

Answer

Diverticulosis

Answer

Pancreatitis

Question 10

What is true about hepatorenal syndrome?

Accepted Answer

It is due to intense hypoperfusion of the kidney.

Answer

It is seen in the advanced stage of cirrhosis.

Answer

Type II has a more serious prognosis than Type I.

Answer

Renal insult is the primary injury.

Gastroenterology — MCQs

Gastroenterology — MCQs

On this page

Practice by Chapter

Want unlimited practice?